Myeloproliferative Neoplasm (MPN) Symptom Assessment Form Total Symptom Score: Prospective International Assessment of an Abbreviated Symptom Burden Scoring System Among Patients With MPNsRobyn M. Emanuel, Ruben A. Mesa, Amylou C. Dueck et al.|Journal of Clinical Oncology|2012Cited by 461
Distinct clustering of symptomatic burden among myeloproliferative neoplasm patients: retrospective assessment in 1470 patientsHolly L. Geyer, Ruben A. Mesa, Björn Andréasson et al.|Blood|2014Cited by 93
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working GroupHolly L. Geyer, Peihong Zhang, Heidi Kosiorek et al.|Haematologica|2016Cited by 73
Symptomatic Profiles of Patients With Polycythemia Vera: Implications of Inadequately Controlled DiseaseHolly L. Geyer, Jan Samuelsson, Robyn M. Scherber et al.|Journal of Clinical Oncology|2015Cited by 65
Thalidomide / Dexamethasone (TD) Vs. Bortezomib (Velcade)a/Thalidomide / Dexamethasone (VTD) Vs. VBMCP/VBAD/Velcadea as Induction Regimens Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Phase III PETHEMA/GEM Trial.Laura Rosiñol, Joan Bladé, M. Teresa Cibeira et al.|Blood|2009Cited by 45